City

Portland (2)

Esplugues de Llobregat (1)

Houghton (1)

Madrid (1)

Nijmegen (1)

Omaha (1)

Valencia (1)

Condition

Mevalonate Kinase Deficiency (3)

Hyper IgD Syndrome (1)

Immune System Diseases (1)

Lipid Metabolism, Inborn Errors (1)

Mevalonic Aciduria (1)

Periodic Fever Syndromes, Hereditary (1)

Overall Status

Completed (1)

Terminated (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Michigan Technological University (1)

Novartis Pharmaceuticals (1)

Oregon Health and Science University (1)

Collaborator

Intervention

canakinumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (2)

Industry (1)

Study Type

Observational (2)

Interventional (1)

mevalonate kinase deficiency

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Dietary Cholesterol and Defects in Cholesterol Synthesis in

Terminated

Mevalonic Aciduria
+4 more

Portland, Oregon

Oregon Health & Science University

May 22, 2019

B7 Coreceptor Molecules in Hyper IgD Syndrome Form of Mevalonate

Withdrawn

Hyper IgD Syndrome
Mevalonate Kinase Deficiency

Houghton, Michigan
+3 more

Jun 14, 2018

Mevalonate Kinase Deficiency Trial in Esplugues de Llobregat, Valencia, Madrid (Canakinumab)

Completed

Has Results

Mevalonate Kinase Deficiency

Canakinumab

Esplugues de Llobregat, Barcelona, Spain
+2 more

Oct 13, 2015